Back

Evaluation of senescence and its prevention in doxorubicin-induced cardiotoxicity using dynamic engineered heart tissues

20 January 2025 (16:37 - 17:00)
Organised by: Logo
Seminar Presentation Part of: Cardiac rejuvenation and regeneration Stem Cells, Cell Cycle, Cell Senescence, Cell Death Delegate Premium access HFA Winter Research Meeting on Translational Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Cardiac protection promoted by BPIFB4 and its longevity-associated haplotype
Professor A. Puca (Salerno, IT)
Slides
Presentation thumbnail
Cardiometabolic adaptations for the enhancement of longevity
Professor D. Aksentijevic (London, GB)
Presentation thumbnail
A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration
Professor L. De Windt (Maastricht, NL)
Slides

Access the full session

Session thumbnail
Cardiac rejuvenation and regeneration

The Event

Event poster

HFA Winter Research Meeting on Translational Heart Failure 2025

20 January 2025 16:37 CET
You may be interested in
thumbnail
Congress Presentation
Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.
22 May 2022
thumbnail
Congress Presentation
HRASV12G overexpression as a driver of senescence in human cardiac fibroblasts
20 June 2025
thumbnail
Webinar
Exercise, rehabilitation and preventive strategies in cardio-oncology
3 December 2025
thumbnail
Congress Presentation
Cardioprotective effects of the flavonoid quercetin against doxorubicin-Induced cardiotoxicity in H9c2 cardiomyoblasts
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources